IntrinsicIntrinsic
← Scroll for more →

Financial Statements — DRMA

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents4.416.957.524.666.489.723.166.144.954.737.446.638.448.776.248.0710.638.1910.8012.60
Inventory0.150.09------------------------------------
Total Current Assets5.16----------------------------------11.6213.69
Property, Plant & Equipment0.13----------------------------------0.000.00
Total Non-current Assets*0.16----------------------------------0.000.00
Total Assets5.327.477.865.076.6410.013.536.695.245.187.987.328.719.306.948.9711.039.0411.6213.69
Accounts Payable1.120.320.460.450.411.400.810.861.330.820.870.470.440.490.500.480.610.660.520.77
Total Current Liabilities------------------------------------1.521.20
Total Non-current Liabilities*------------------------------------0.000.00
Total Liabilities1.831.051.641.111.032.701.971.951.921.371.620.920.681.210.921.501.371.191.521.20
Retained Earnings(78.05)(75.08)(73.23)(71.37)(69.68)(67.98)(65.68)(62.52)(59.35)(56.52)(53.39)(51.25)(49.53)(47.83)(45.59)(43.92)(41.50)(38.77)(35.98)(33.43)
Total Stockholder Equity3.496.416.223.965.617.301.564.743.323.816.366.418.038.096.027.479.667.8510.1112.49
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Research & Development0.210.380.530.500.621.282.192.402.011.601.140.900.841.190.891.551.611.601.110.80
Selling, General & Admin2.801.541.371.261.151.061.010.820.871.601.080.910.891.090.820.891.121.191.440.91
Total Operating Expenses3.011.931.901.761.772.343.203.232.883.202.221.811.732.28------------
Operating Income(3.01)(1.93)(1.90)(1.76)(1.77)(2.34)(3.20)(3.23)(2.88)(3.20)(2.22)(1.81)(1.73)(2.28)(1.71)(2.45)(2.73)(2.79)(2.55)(1.71)
Interest Expense--------------------------------0.000.000.000.00
Net Income(2.97)(1.85)(1.86)(1.69)(1.70)(2.30)(3.15)(3.17)(2.83)(3.13)(2.13)(1.72)(1.70)(2.24)(1.67)(2.42)(2.73)(2.79)(2.55)(1.71)
Basic EPS(0.74)(0.48)(4.40)(1.65)(1.66)(0.45)61.26------0.77(0.54)(0.63)(2.27)6.52----(0.33)----
Diluted EPS(0.74)(0.48)(4.40)(1.65)(1.66)(0.45)61.26--------------------------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(2.42)(2.48)(1.33)(1.80)(2.69)(1.93)(2.91)(3.42)(2.13)(2.70)(1.15)(1.77)(1.84)(1.65)(1.83)(2.56)(1.84)(2.61)(9.58)5.57
Capital Expenditures0.11--------------------------------------
Free Cash Flow*(2.53)--------------------------------------
Investing Cash Flow(0.11)--------------------------------------
Financing Cash Flow-0.001.904.19(0.01)(0.55)8.49(0.07)4.622.340.001.95(0.04)1.514.180.000.004.280.00-0.0014.39
← Scroll for more columns →

* Derived from reported values